Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Koichi Nisijima. (2023) Neuroleptic Malignant Syndrome Improved with Intramuscular Administration of the Anticholinergic Agent, Biperiden. International Medical Case Reports Journal 16, pages 281-286.
Read now
Read now
Ramadhan Oruch, Ian F Pryme, Bernt A Engelsen & Anders Lund. (2017) Neuroleptic malignant syndrome: an easily overlooked neurologic emergency. Neuropsychiatric Disease and Treatment 13, pages 161-175.
Read now
Read now
Articles from other publishers (13)
Yan Lin, Lin Ma, Nan Zhang, Ruihua Li & Wenjing Jiang. (2022) Neuroleptic malignant-like syndrome associated multiple system atrophy: report on three cases. BMC Neurology 22:1.
Crossref
Crossref
Upinder Kaur, Kumudini Acharya, Amit Singh, Indrajeet Singh Gambhir & Sankha Shubhra Chakrabarti. (2021) Levosulpiride associated neuroleptic malignant syndrome in an elderly patient: a tale of confusing brand names. Acta Neurologica Belgica 122:4, pages 1103-1105.
Crossref
Crossref
Siddiqa Ozaal & Gaya Katulanda. (2022) Exceptionally high creatine kinase levels in risperidone-induced neuroleptic malignant syndrome: A case report. SAGE Open Medical Case Reports 10, pages 2050313X2210850.
Crossref
Crossref
Yuhei Mori, Itaru Miura, Michinari Nozaki, Yusuke Osakabe, Ryuta Izumi, Takahiro Akama, So Kimura & Hirooki Yabe. (2021) Electroconvulsive Therapy for Parkinson's Disease with Depression and Neuroleptic Malignant Syndrome: A Case Report. Clinical Psychopharmacology and Neuroscience 19:3, pages 572-575.
Crossref
Crossref
Ho-Man Yeung, Sarah Schmitz, Nino Kvantaliani & Christina Martin. (2021) Development of Neuroleptic Malignant Syndrome in a Patient with Lewy Body Dementia after Intramuscular Administration of Paliperidone. Case Reports in Neurological Medicine 2021, pages 1-4.
Crossref
Crossref
Hein Bokern, Niels Jonker & Dan Cohen. (2020) Creatine kinase elevation and discontinuation of clozapine: fear-driven clinical practice in a forensic case with treatment-resistant schizophrenia and persistent violent behaviour. BJPsych Open 7:1.
Crossref
Crossref
Sandra Nora Gonzalez-Diaz, Cindy Elizabeth de Lira-Quezada, Rosalaura Virginia Villarreal-Gonzalez, Rosa Ivett Guzman-Avilan, Carlos Macouzet-Sanchez & Gabriela Galindo-Rodriguez. (2020) Perioperative Anaphylaxis. Current Treatment Options in Allergy 7:2, pages 198-210.
Crossref
Crossref
Müge Ayanoğlu, Elif Korgali, Taner Sezer, Halil Ibrahim Aydin & Fatma Müjgan Sönmez. (2020) Coexistence of guanidinoacetate methyltransferase (GAMT) deficiency and neuroleptic malignant syndrome without creatine kinase elevation. Brain and Development 42:5, pages 418-420.
Crossref
Crossref
Harsh Sahu, Mouna Bidarguppe Manjunath, Animesh Ray & Naval Kishore Vikram. (2018) Neuroleptic malignant-like syndrome causing thrombocytopaenia: a rare association. BMJ Case Reports 11:1, pages bcr-2018-227089.
Crossref
Crossref
Nicole M. Schreiner, Samuel Windham & Andrew Barker. (2017) Atypical Neuroleptic Malignant Syndrome. A & A Case Reports 9:12, pages 339-343.
Crossref
Crossref
Osnat Wittmann, Efraim Sadot, Orly Bisker-Kassif, Dennis Scolnik, Oren Tavor & Miguel M. Glatstein. (2016) Neuroleptic Malignant Syndrome Associated With Metoclopramide Use in a Boy: Case Report and Review of the Literature. American Journal of Therapeutics 23:5, pages e1246-e1249.
Crossref
Crossref
Michael P. Wilson, Gary M. Vilke, Stephen R. Hayden & Kimberly Nordstrom. (2016) Psychiatric Emergencies for Clinicians: Emergency Department Management of Neuroleptic Malignant Syndrome. The Journal of Emergency Medicine 51:1, pages 66-69.
Crossref
Crossref
. (2014) Antipsychotics. Reactions Weekly 1524:1, pages 38-38.
Crossref
Crossref